Find uplifting stories about heroes, innovations, and solutions
11846 results for "fda breakthrough therapy"
The FDA just created a faster pathway for patients with rare genetic disorders to access personalized gene therapies without lengthy clinical trials. While some experts celebrate this breakthrough for desperately ill patients, others urge caution about adequate safety monitoring.
Researchers who developed the first FDA-approved gene therapy for inherited blindness are among this year's $3 million Breakthrough Prize winners. Their work is opening doors for treatments that were once considered impossible.
Children born with a life-threatening immune disorder now have hope thanks to a newly approved gene therapy that could save their lives with a single treatment. The FDA just greenlit Kresladi, a breakthrough for severe LAD-1 that leaves kids defenseless against infections.
A groundbreaking gene-editing treatment could reach patients faster than ever before, as Prime Medicine asks the FDA to approve their therapy after just two successful treatments. The drug uses a revolutionary CRISPR technique to fix a genetic disorder that leaves patients vulnerable to deadly infections.
The FDA just made it easier for life-saving gene therapies to reach patients with ultra-rare diseases who previously had few treatment options. The new pathway means families won't have to wait years for cures when the science shows real promise.
President Trump signed an executive order to speed FDA review of psychedelic treatments showing 80-90% reduction in PTSD symptoms among veterans. The breakthrough therapy could help over 6,000 veterans who die by suicide each year.
A groundbreaking gene therapy just won FDA approval for children born deaf from a rare genetic condition. Kids who once moved their lips silently are now hearing their own voices for the first time.
The FDA reversed course on a groundbreaking gene therapy for Huntington's disease, bringing new hope to thousands of families. The treatment from biotech company UniQure can now move forward toward U.S. approval.
Children born deaf are now hearing their mother's voice for the first time, thanks to a groundbreaking gene therapy that restores natural hearing. The FDA just approved the treatment, and the company is offering it completely free across the United States.
Children as young as 2 can now access a breakthrough gene therapy that could eliminate the need for lifelong blood transfusions. The FDA just expanded approval of Casgevy, a one-time CRISPR treatment that edits a patient's own cells to fight sickle cell disease.
Children born deaf from a genetic mutation can now hear naturally thanks to a groundbreaking gene therapy just approved by the FDA. The one-time treatment restores a missing protein in the inner ear, allowing sound signals to reach the brain.
Children born with a specific type of genetic hearing loss can now hear their parents' voices and dance to music, thanks to the FDA's approval of the first-ever gene therapy for inherited deafness. The one-time treatment helps patients avoid cochlear implants and restores natural hearing.
The FDA just approved the first gene therapy to treat genetic hearing loss, giving hope to dozens of families each year whose babies are born deaf. Even better? The company is making it free for all U.S. patients.
The FDA just made it easier for millions of Americans with rare diseases to access life-saving gene therapies without waiting years for traditional clinical trials. Families who were told to "wait for science to catch up" now have real hope.
The FDA is accelerating breakthrough psychedelic therapies for treatment-resistant depression, PTSD, and alcohol use disorder after a presidential directive. Veterans and millions struggling with serious mental illness could gain access to promising new options backed by rigorous science.
The FDA just unveiled a breakthrough framework that could bring life-saving gene therapies to thousands of children with rare diseases in a fraction of the time. For families who've watched their kids suffer while treatments stall, this changes everything.
Scientists who created gene therapies that cure inherited blindness and blood disorders just won six $3 million prizes. Their discoveries are transforming devastating diseases from hopeless diagnoses into treatable conditions.
A one-week-old baby received groundbreaking gene therapy for a fatal disease just days after FDA approval, transforming what doctors once called a "death sentence" into a life full of possibility. Today, 10-month-old Samuel is crawling, smiling, and showing no signs of the disease that would have confined him to a wheelchair.
%2Cfit(1200%2C675)%2Cquality(65))
Children as young as two can now receive a groundbreaking gene therapy that offers a potential cure for sickle cell disease. The FDA's approval of Casgevy marks a historic expansion that could prevent irreversible damage before it starts.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2Fcf%2Fcd%2Fcfcd970f-b205-4a58-b5c2-3c656d99b432%2Fbaby-hearing-test.jpg)
A groundbreaking gene therapy now offers hope to children born with a rare form of deafness, with 80% of trial participants gaining significant hearing within a year. Even better, the maker plans to provide it free to U.S. patients.
Showing 20 of 11846